The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has reversed an earlier decision and now recommends that a pediatric-use marketing authorization (PUMA) be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback